ABPS GI Endoscopy study materials
ABPS GI Endoscopy study resources

Warfarin, a Mechanical Valve, and a Screening Colonoscopy

ABPS GI Endoscopy · Put your knowledge to work in context.

All case studies

Warfarin, a Mechanical Valve, and a Screening Colonoscopy

71-year-old man with a mechanical mitral valve, atrial fibrillation, and stage 4 chronic kidney disease (eGFR 28) is scheduled for screening colonoscopy in 48 hours after a positive FIT. He stopped warfarin 3 days ago because a friend told him it would 'prevent bleeding'; no bridging was arranged. Today his INR is 3.4. He feels well and has no melena, hematemesis, or syncope. The endoscopy unit policy allows diagnostic colonoscopy at an INR above 1.5 only after cardiology review, but requires INR 1.5 or less before polypectomy. He asks whether he can simply proceed and 'get it over with.'

1. What is your immediate decision about proceeding with colonoscopy in 48 hours, and what actions do you take today? Explain the competing risks.

Read the worked answer

Do not proceed as scheduled. This is an elective screening colonoscopy after a positive FIT, with no obstruction, perforation, or active hemorrhage. The dominant immediate risk is thromboembolic: a mechanical mitral valve plus atrial fibrillation places him at high risk for valve thrombosis and stroke, and warfarin was already stopped 3 days ago without a bridging plan. Proceeding at INR 3.4 would either require urgent reversal (adding thrombotic risk) or create a high bleeding risk if a polyp is found.

Today: (1) contact cardiology for same-day advice on restarting warfarin and whether bridging with LMWH is indicated; (2) check hemoglobin, platelets, creatinine, and symptoms; (3) restart warfarin at his prior dose unless cardiology directs otherwise; (4) do not give vitamin K simply to lower INR for an elective procedure; (5) reschedule after cardiology clearance and an agreed INR target.

Document the shared decision and the reasons for delay.

2. When you reschedule, what bowel preparation and periprocedural plan do you choose for stage 4 CKD, and why?

Read the worked answer

Use a split-dose PEG-based preparation, preferably a low-volume 2 L PEG with ascorbate if available, rather than sodium phosphate or a magnesium-based agent. Sodium phosphate can cause acute phosphate nephropathy, especially with eGFR 28, and magnesium can accumulate in renal impairment.

Plan:

  • Confirm no bowel obstruction and review diuretics/ACE inhibitors with the nephrologist.
  • Give clear written instructions: first dose the evening before, second dose 4-6 hours before the procedure; nothing by mouth 2 hours before.
  • Encourage clear fluids; check electrolytes and creatinine before and after if there is vomiting or poor intake.
  • Ensure a responsible escort, safe transport, and a plan for anticoagulation held or continued according to cardiology.
  • If prep is inadequate, reschedule rather than performing a low-quality examination.

3. What must the informed-consent discussion cover beyond the standard colonoscopy risks?

Read the worked answer

Cover the specific trade-off created by his mechanical valve and interrupted warfarin: stroke, valve thrombosis, and systemic embolism if anticoagulation is inadequate, versus gastrointestinal bleeding if the INR is therapeutic or supratherapeutic. Explain that a positive FIT warrants colonoscopy, but that a short delay to coordinate anticoagulation is safer than an urgent reversal.

Discuss alternatives honestly: repeat FIT is not equivalent to colonoscopy after a positive result; CT colonography can evaluate the colon but cannot remove polyps and still requires bowel prep and anticoagulation planning. Explain the possibility of an inadequate prep, repeat procedure, sedation risks, perforation, and missed lesions. Confirm he understands, has capacity, is deciding voluntarily, and has had time to ask questions. Document who was present and the plan for cardiology clearance.